Viewing Study NCT02938728


Ignite Creation Date: 2025-12-26 @ 10:33 AM
Ignite Modification Date: 2026-03-05 @ 2:26 PM
Study NCT ID: NCT02938728
Status: UNKNOWN
Last Update Posted: 2016-10-25
First Post: 2016-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module